Clinical trial
Minocycline Dosing and Safety in Huntington's Disease
NCT00029874 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minocycline Dosing and Safety in Huntington's Disease
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2001
- Completion date
- August 31, 2003
- Enrollment
- 63
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
huntington's disease